Together with recent identification of a small molecule selectively inhibiting ERG-positive cancer cells88, we expect additive effects among these drugs to inhibit the interaction and expression of ERG and HNF1B or their target genes thereby affecting PCa cell growth in the clinical setting as an important topic for future studies. Here, HNF1B is linked to posterior cortical atrophy.